* NSE, BSE indexes down about 1 pct
* Asian stocks fall after weak China data
* Reliance Industries down 1.5 pct, TCS down 2.1 pct
Oct 13 Indian shares fell on Thursday, dragged
lower by heavyweights such as Reliance Industries as
well as financial and technology stocks, signalling low risk
appetite among investors ahead of some key company results.
Indexes in Asia's second-largest economy tracked losses in
regional shares after weak China trade data rekindled global
China's September exports fell 10 percent from a year
earlier, far more than markets had expected, while imports
unexpectedly shrank 1.9 percent.
Back home, caution prevailed ahead of quarterly results of
software exporter Tata Consultancy Services, which fell
2.1 percent. TCS is expected to report results on Thursday after
the market closes, ahead of Infosys' results, which is
due on Friday.
"China has been a concern for a very long time and today's
data indicates that exports are not up to the mark. So markets
are seeing a correction. But going ahead, focus remains on
quarterly results," said AK Prabhakar, head of research at IDBI
The benchmark BSE index was 0.85 percent lower at
27,848.71 as of 0512 GMT, while the NSE index was down
0.92 percent at 8,628.32. Both indexes hit their lowest in two
Indian financial markets were shut on Tuesday and Wednesday
for public holidays.
Index heavyweights such as Reliance Industries was down 1.5
percent while Housing Development Finance Corp
declined 2.5 percent.
Mining stocks such as Hindalco Industries and
Vedanta Ltd also fell more than 1.5 percent.
The Nifty Metal index was down nearly 1 percent,
reflecting weakness in global metal prices after exports at the
world's biggest metals consumer China fell more than expected in
Blue Dart Express fell 2.7 percent after the
package delivery company reported a near 21 percent drop in
September-quarter profit, missing analysts' estimates.
Among the gainers, IndusInd Bank rose as much as 2
percent after the lender on Wednesday posted a near-26 percent
rise in September-quarter profit.
Cipla rose 1.3 percent after the drugmaker said on
Wednesday that the U.S. Food and Drug Administration cleared its
manufacturing facility at Indore.
(Reporting by Aastha Agnihotri in Bengaluru; Editing by Amrutha